Summary The role of genetic risk factors in genetic screening for prevention of heart disease
is yet to be defined. The technology is already available, but functional analysis may be a prerequisite for their clinical application.”
“Four kinds of biorefinery residues (the ethanol, the butanol, the xylitol and the lactic acid biorefinery residue) were utilized to modify the phenol-formaldehyde (PF) resin, respectively by copolymerization. Prior to the reaction, the LY3023414 composition and functional group of each biorefinery residue were characterized and used to evaluate their suitability as replacement for the preparation of PF resins. It was found that ER (bio-ethanol biorefinery residue) exhibited high reactivity due to high content of hydroxyl group. The influence of each biorefinery residue for the replacement of phenol on the properties of residue-modified phenol formaldehyde (RPF) resins was also investigated using Fourier transform infrared spectroscopy (FT-IR), solid state (CNMR)-C-13 and thermo gravimetric analyzer (TGA). ER was found to be the best biorefinery residue for the modification of PF resin. 50% phenol could be replaced by ER without influencing the properties of adhesives and plywoods. In industrial production, the plywoods bonded by ER-derived PF resins met the requirement of both first grade and E-0 grade (GB/T 9846.3-2004). (C) 2012 Elsevier B.V. All rights reserved.”
“BACKGROUND: Minimally
invasive surgical P005091 mouse procedures
such as tension-free vaginal tape sling should not imply that a minimal preoperative evaluation is all that is required.
CASE: A 52-year-old multiparous perimenopausal woman presented with postoperative nausea, vomiting, and vague abdominal-pelvic discomfort after placement of tension-free Birinapant in vitro vaginal tape. The final diagnosis was invasive molar pregnancy.
CONCLUSION: This case raises the awareness of the rare diagnosis of gestational trophoblastic disease in perimenopausal women and emphasizes the importance of a complete preoperative evaluation in those scheduled to undergo minimally invasive procedures. (Obstet Gynecol 2011; 117: 487-8) DOI: 10.1097/AOG.0b013e3182055efc”
“Purpose of review We will review the role of microRNAs (miRNAs), small noncoding RNAs with regulatory function, in myocardial infarction (MI). Specifically, we will examine the effect of MI on miRNAs’ expression in the heart, the effect of MI on circulating miRNAs, which miRNAs’ overexpression or downmodulation appears to have a therapeutic role in MI and which cardiac miRNAs are modulated by drugs/experimental molecules/cell transplantation strategies which have an established or potential therapeutic role in MI.
Recent findings A rapidly increasing number of studies are showing that cardiac and circulating miRNAs are markedly altered in MI. These novel findings shed new light on the mechanisms that lead to MI complications, post-MI ventricular remodeling and cardiac repair.